XDx Files for Review of Source MDx's Gene Expression Monitoring Patent | GenomeWeb
This article has been updated to include a comment from Source MDx.
 
NEW YORK (GenomeWeb News) – Molecular diagnostics developer XDx has asked the US Patent and Trademark Office to review a patent for immune system monitoring methods based on gene expression, the company said today. The patent, No. 6,964,850, was originally filed in 2002 and was assigned to the Boulder, Colo.-based company Source MDx.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.